Essentially, the study suggests that an FMD can reprogram pancreatic cells to renew insulin production in type 1 diabetes patients’ islets and mitigate symptoms of both type 1 and type 2 diabetes in mice (4). The gene discussed is INS; the disease is type 1 diabetes mellitus.